Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Push To Lead OTC Space Relies On Distribution, Emerging Markets

This article was originally published in PharmAsia News

Executive Summary

Bayer expands its distribution, invests in emerging markets and innovation and acquires strategic bolt-ons in an attempt to replace Johnson & Johnson as the largest global OTC business, executives say. Growth areas include gastrointestinal and cough/cold products, but not Rx-to-OTC switch.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC084701

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel